By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will partner with EdgeBio and Virginia Commonwealth University in a project that will study how gene regulation and epigenetic markers may be involved in the development of schizophrenia.

The research will involve using Life Technologies' SOLiD System and MethylMiner methylated DNA enrichment kit to conduct genome-wide sequencing and methylation studies of 1,500 individuals, the company said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.